{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T04:28:45Z","timestamp":1744172925747,"version":"3.40.3"},"reference-count":93,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T00:00:00Z","timestamp":1299283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,3,5]],"date-time":"2011-03-05T00:00:00Z","timestamp":1299283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1007\/s12098-011-0384-2","type":"journal-article","created":{"date-parts":[[2011,3,6]],"date-time":"2011-03-06T22:32:43Z","timestamp":1299450763000},"page":"845-853","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Update on Available Vaccines in India: Report of the APPA VU 2010: I"],"prefix":"10.1007","volume":"78","author":[{"given":"Sunil","family":"Karande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,3,5]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/S0140-6736(10)60549-1","volume":"375","author":"RE Black","year":"2010","unstructured":"Black RE, Cousens S, Johnson HL, et al. Child Health Epidemiology Reference Group of WHO and UNICEF. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969\u201387.","journal-title":"Lancet"},{"key":"384_CR2","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S0140-6736(09)61203-4","volume":"374","author":"JP Watt","year":"2009","unstructured":"Watt JP, Wolfson LJ, O\u2019Brien KL, et al. Hib and Pneumococcal Global Burden of Disease Study Team. Burden of disease caused by Haemophilus influenzae type b in children younger than 5\u00a0years: global estimates. Lancet. 2009;374:903\u201311.","journal-title":"Lancet"},{"key":"384_CR3","first-page":"445","volume":"81","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. WHO position paper on Haemophilus influenzae type b conjugate vaccines. Wkly Epidemiol Rec. 2006;81:445\u201352.","journal-title":"Wkly Epidemiol Rec"},{"key":"384_CR4","first-page":"649","volume":"131","author":"M Gupta","year":"2010","unstructured":"Gupta M, Kumar R, Deb AK, et al. Hib Study Working Group. Multi-center surveillance for pneumonia & meningitis among children (<2\u00a0yr) for Hib vaccine probe trial preparation in India. Indian J Med Res. 2010;131:649\u201358.","journal-title":"Indian J Med Res"},{"key":"384_CR5","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/INF.0b013e318199f2a1","volume":"28","author":"VP Verghese","year":"2009","unstructured":"Verghese VP, Friberg IK, Cherian T, et al. Community effect of Haemophilus influenzae type b vaccination in India. Pediatr Infect Dis J. 2009;28:738\u201340.","journal-title":"Pediatr Infect Dis J"},{"key":"384_CR6","first-page":"945","volume":"46","author":"NTAGI subcommittee recommendations on","year":"2009","unstructured":"NTAGI subcommittee recommendations on Haemophilus influenzae type B (Hib) vaccine introduction in India. Indian Pediatr. 2009;46:945\u201354.","journal-title":"Indian Pediatr"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijid.2005.10.007","volume":"11","author":"MK Sudarshan","year":"2007","unstructured":"Sudarshan MK, Madhusudana SN, Mahendra BJ, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis. 2007;11:29\u201335.","journal-title":"Int J Infect Dis"},{"key":"384_CR8","doi-asserted-by":"publisher","first-page":"890","DOI":"10.2471\/BLT.09.021209","volume":"87","author":"P Chatterjee","year":"2009","unstructured":"Chatterjee P. India\u2019s ongoing war against rabies. Bull World Health Organ. 2009;87:890\u20131.","journal-title":"Bull World Health Organ"},{"key":"384_CR9","first-page":"32","volume":"38","author":"MK Sudarshan","year":"2006","unstructured":"Sudarshan MK, Mahendra BJ, Madhusudana SN, et al. Association for Prevention and Control of Rabies in India (APCRI). An epidemiological study of animal bites in India: results of a WHO sponsored national multi-centric rabies survey. J Commun Dis. 2006;38:32\u20139.","journal-title":"J Commun Dis"},{"key":"384_CR10","unstructured":"WHO Expert Consultation on Rabies. World Health Organ Tech Rep Ser. 2005;931:1\u201388."},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"365","DOI":"10.4161\/hv.4.5.5987","volume":"4","author":"P Shanbag","year":"2008","unstructured":"Shanbag P, Shah N, Kulkarni M, et al. Protecting Indian schoolchildren against rabies: pre-exposure vaccination with purified chick embryo cell vaccine (PCECV) or purified verocell rabies vaccine (PVRV). Hum Vaccin. 2008;4:365\u20139.","journal-title":"Hum Vaccin"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1016\/j.vaccine.2010.02.093","volume":"28","author":"B Dodet","year":"2010","unstructured":"Dodet B, Asian Rabies Expert Bureau (AREB). Report of the sixth AREB meeting, Manila, The Philippines, 10\u201312 November 2009. Vaccine. 2010;28:3265\u20138.","journal-title":"Vaccine"},{"key":"384_CR13","first-page":"939","volume":"46","author":"TJ John","year":"2009","unstructured":"John TJ, Choudhury P. Accelerating measles control in India opportunity and obligation to act now. Indian Pediatr. 2009;46:939\u201343.","journal-title":"Indian Pediatr"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1016\/j.vaccine.2009.09.116","volume":"27","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. WHO position on measles vaccines. Vaccine. 2009;27:7219\u201321.","journal-title":"Vaccine"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"4070","DOI":"10.1016\/j.vaccine.2004.10.020","volume":"23","author":"R Harling","year":"2005","unstructured":"Harling R, White JM, Ramsay ME, Macsween KF, van den Bosch C. The effectiveness of the mumps component of the MMR vaccine: a case control study. Vaccine. 2005;23:4070\u20134.","journal-title":"Vaccine"},{"key":"384_CR16","first-page":"12","volume":"13","author":"C Cohen","year":"2007","unstructured":"Cohen C, White JM, Savage EJ, et al. Vaccine effectiveness estimates, 2004\u20132005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12\u20137.","journal-title":"Emerg Infect Dis"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1128\/CVI.00246-07","volume":"14","author":"SK Raut","year":"2007","unstructured":"Raut SK, Kulkarni PS, Phadke MA, et al. Persistence of antibodies induced by measles-mumps-rubella vaccine in children in India. Clin Vaccine Immunol. 2007;14:1370\u20131.","journal-title":"Clin Vaccine Immunol"},{"key":"384_CR18","first-page":"51","volume":"82","author":"Anonymous","year":"2007","unstructured":"Anonymous. Mumps virus vaccines. Wkly Epidemiol Rec. 2007;82:51\u201360.","journal-title":"Wkly Epidemiol Rec"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vaccine.2006.07.039","volume":"25","author":"CP Muller","year":"2007","unstructured":"Muller CP, Kremer JR, Best JM, Dourado I, Triki H, Reef S. WHO Steering Committee for Measles and Rubella. Reducing global disease burden of measles and rubella: report of the WHO Steering Committee on research related to measles and rubella vaccines and vaccination, 2005. Vaccine. 2007;25:1\u20139.","journal-title":"Vaccine"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"2708","DOI":"10.1016\/S0264-410X(03)00229-9","volume":"21","author":"E Vynnycky","year":"2003","unstructured":"Vynnycky E, Gay NJ, Cutts FT. The predicted impact of private sector MMR vaccination on the burden of congenital rubella syndrome. Vaccine. 2003;21:2708\u201319.","journal-title":"Vaccine"},{"key":"384_CR21","first-page":"51","volume":"123","author":"N Ramamurty","year":"2006","unstructured":"Ramamurty N, Murugan S, Raja D, Elango V, Mohana S, Dhanagaran D. Serosurvey of rubella in five blocks of Tamil Nadu. Indian J Med Res. 2006;123:51\u20134.","journal-title":"Indian J Med Res"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"e1070","DOI":"10.1542\/peds.2005-2085","volume":"117","author":"AS Lopez","year":"2006","unstructured":"Lopez AS, Guris D, Zimmerman L, et al. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose? Pediatrics. 2006;117:e1070\u20137.","journal-title":"Pediatrics"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","volume":"23","author":"B Kuter","year":"2004","unstructured":"Kuter B, Matthews H, Shinefield H, et al. Study Group for Varivax. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004;23:132\u20137.","journal-title":"Pediatr Infect Dis J"},{"key":"384_CR24","first-page":"1","volume":"56","author":"M Marin","year":"2007","unstructured":"Marin M, Guris D, Chaves SS, Schmid S, Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1\u201340.","journal-title":"MMWR Recomm Rep"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa064040","volume":"356","author":"SS Chaves","year":"2007","unstructured":"Chaves SS, Gargiullo P, Zhang JX, et al. Loss of vaccine-induced immunity to varicella over time. N Engl J Med. 2007;356:1121\u20139.","journal-title":"N Engl J Med"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"e744","DOI":"10.1542\/peds.2008-0567","volume":"122","author":"M Marin","year":"2008","unstructured":"Marin M, Meissner HC, Seward JF. Varicella prevention in the United States: a review of successes and challenges. Pediatrics. 2008;122:e744\u201351.","journal-title":"Pediatrics"},{"key":"384_CR27","first-page":"719","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward poliomyelitis eradication\u2014India, January 2007\u2013May 2009. MMWR Morb Mortal Wkly Rep. 2009;58:719\u201323.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1126\/science.1130388","volume":"314","author":"NC Grassly","year":"2006","unstructured":"Grassly NC, Fraser C, Wenger J, et al. New strategies for the elimination of polio from India. Science. 2006;314:1150\u20133.","journal-title":"Science"},{"key":"384_CR29","first-page":"545","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","unstructured":"Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission\u2014worldwide, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:545\u201350.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1016\/S0140-6736(10)61427-4","volume":"376","author":"NW Crawford","year":"2010","unstructured":"Crawford NW, Buttery JP. Poliomyelitis eradication: another step forward. Lancet. 2010;376:1624\u20135.","journal-title":"Lancet"},{"key":"384_CR31","first-page":"53","volume":"82","author":"TJ John","year":"2004","unstructured":"John TJ. A developing country perspective on vaccine-associated paralytic poliomyelitis. Bull World Health Organ. 2004;82:53\u20137.","journal-title":"Bull World Health Organ"},{"key":"384_CR32","first-page":"491","volume":"130","author":"TJ John","year":"2009","unstructured":"John TJ, Vashishtha VM. Eradication of vaccine polioviruses: why, when & how? Indian J Med Res. 2009;130:491\u20134.","journal-title":"Indian J Med Res"},{"key":"384_CR33","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1016\/j.vaccine.2008.07.026","volume":"26","author":"MC Bonnet","year":"2008","unstructured":"Bonnet MC, Dutta A. World wide experience with inactivated poliovirus vaccine. Vaccine. 2008;26:4978\u201383.","journal-title":"Vaccine"},{"key":"384_CR34","first-page":"635","volume":"5","author":"Indian Academy of Pediatrics Committee on Immunization (IAPCOI)","year":"2008","unstructured":"Indian Academy of Pediatrics Committee on Immunization (IAPCOI). Consensus recommendations on immunization, 2008. Indian Pediatr. 2008;5:635\u201348.","journal-title":"Indian Pediatr"},{"key":"384_CR35","doi-asserted-by":"publisher","first-page":"E51","DOI":"10.1542\/peds.106.4.e51","volume":"106","author":"MM Braun","year":"2000","unstructured":"Braun MM, Mootrey GT, Salive ME, Chen RT, Ellenberg SS. Infant immunization with acellular pertussis vaccines in the United States: assessment of the first two years\u2019 data from the Vaccine Adverse Event Reporting System (VAERS). Pediatrics. 2000;106:E51.","journal-title":"Pediatrics"},{"key":"384_CR36","doi-asserted-by":"publisher","first-page":"E52","DOI":"10.1542\/peds.106.4.e52","volume":"106","author":"TS DuVernoy","year":"2000","unstructured":"DuVernoy TS, Braun MM. Hypotonic-hyporesponsive episodes reported to the Vaccine Adverse Event Reporting System (VAERS), 1996\u20131998. Pediatrics. 2000;106:E52.","journal-title":"Pediatrics"},{"key":"384_CR37","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1542\/peds.112.5.e348","volume":"112","author":"N Le Saux","year":"2003","unstructured":"Le Saux N, Barrowman NJ, Moore DL, Whiting S, Scheifele D, Halperin S, et al. Decrease in hospital admissions for febrile seizures and reports of hypotonic-hyporesponsive episodes presenting to hospital emergency departments since switching to acellular pertussis vaccine in Canada: a report from IMPACT. Pediatrics. 2003;112:e348.","journal-title":"Pediatrics"},{"key":"384_CR38","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2165\/00003495-200565100-00005","volume":"65","author":"JR Casey","year":"2005","unstructured":"Casey JR, Pichichero ME. Acellular pertussis vaccine safety and efficacy in children, adolescents and adults. Drugs. 2005;65:1367\u201389.","journal-title":"Drugs"},{"key":"384_CR39","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1542\/peds.2009-1496","volume":"126","author":"WT Huang","year":"2010","unstructured":"Huang WT, Gargiullo PM, Broder KR, et al. Vaccine Safety Datalink Team. Lack of association between acellular pertussis vaccine and seizures in early childhood. Pediatrics. 2010;126:263\u20139.","journal-title":"Pediatrics"},{"key":"384_CR40","first-page":"471","volume-title":"Vaccines","author":"KM Edwards","year":"2004","unstructured":"Edwards KM, Decker MD. Pertussis vaccines. In: Plotkin SA, Orenstein WA, editors. Vaccines. 4th ed. Philadelphia: Saunders; 2004. pp. 471\u2013528.","edition":"4"},{"key":"384_CR41","doi-asserted-by":"publisher","first-page":"e285","DOI":"10.1542\/peds.2004-2759","volume":"116","author":"KM Bisgard","year":"2005","unstructured":"Bisgard KM, Rhodes P, Connelly BL, Bi D, Hahn C, Patrick S, et al. Pertussis vaccine effectiveness among children 6 to 59\u00a0months of age in the United States, 1998\u20132001. Pediatrics. 2005;116:e285\u201394.","journal-title":"Pediatrics"},{"key":"384_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/adc.2006.106724","volume":"92","author":"AJ Pollard","year":"2007","unstructured":"Pollard AJ. New combination vaccines still need a boost. Arch Dis Child. 2007;92:1\u20132.","journal-title":"Arch Dis Child"},{"key":"384_CR43","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","volume":"374","author":"KL O\u2019Brien","year":"2009","unstructured":"O\u2019Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5\u00a0years: global estimates. Lancet. 2009;374:893\u2013902.","journal-title":"Lancet"},{"key":"384_CR44","doi-asserted-by":"publisher","first-page":"7282","DOI":"10.1016\/j.vaccine.2009.04.046","volume":"27","author":"LC Bravo","year":"2009","unstructured":"Bravo LC, Asian Strategic Alliance for Pneumococcal Disease Prevention (ASAP) Working Group. Overview of the disease burden of invasive pneumococcal disease in Asia. Vaccine. 2009;27:7282\u201391.","journal-title":"Vaccine"},{"key":"384_CR45","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J Infect Dis. 2010;201:32\u201341.","journal-title":"J Infect Dis"},{"key":"384_CR46","doi-asserted-by":"publisher","first-page":"e197","DOI":"10.1016\/j.ijid.2009.05.010","volume":"14","author":"DJ Isaacman","year":"2010","unstructured":"Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis. 2010;14:e197\u2013209.","journal-title":"Int J Infect Dis"},{"key":"384_CR47","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/S0140-6736(98)07228-6","volume":"353","author":"Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN)","year":"1999","unstructured":"Invasive Bacterial Infection Surveillance (IBIS) Group, International Clinical Epidemiology Network (INCLEN). Prospective multicentre hospital surveillance of Streptococcus pneumoniae disease in India. Lancet. 1999;353:1216\u201321.","journal-title":"Lancet"},{"key":"384_CR48","first-page":"127","volume":"114","author":"R Kanungo","year":"2001","unstructured":"Kanungo R, Rajalakshmi B. Serotype distribution & antimicrobial resistance in Streptococcus pneumoniae causing invasive & other infections in South India. Indian J Med Res. 2001;114:127\u201332.","journal-title":"Indian J Med Res"},{"key":"384_CR49","unstructured":"World Health Organization. Pneumococcal conjugate vaccine for childhood immunization\u2014WHO position paper. 2007;82:93\u2013104."},{"key":"384_CR50","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1001\/jama.297.16.1784","volume":"297","author":"RJ Singleton","year":"2007","unstructured":"Singleton RJ, Hennessy TW, Bulkow LR, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA. 2007;297:1784\u201392.","journal-title":"JAMA"},{"key":"384_CR51","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/INF.0b013e3181c15471","volume":"29","author":"KK Hsu","year":"2010","unstructured":"Hsu KK, Shea KM, Stevenson AE, Massachusetts Department of Public Health. Changing serotypes causing childhood invasive pneumococcal disease: Massachusetts, 2001\u20132007. Pediatr Infect Dis J. 2010;29:289\u201393.","journal-title":"Pediatr Infect Dis J"},{"key":"384_CR52","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1586\/erv.10.127","volume":"9","author":"GT Rijkers","year":"2010","unstructured":"Rijkers GT, van Mens SP, van Velzen-Blad H. What do the next 100\u00a0years hold for pneumococcal vaccination? Expert Rev Vaccines. 2010;9:1241\u20134.","journal-title":"Expert Rev Vaccines"},{"key":"384_CR53","first-page":"1255","volume":"57","author":"Centers for Disease Control and Prevention (CDC)","year":"2008","unstructured":"Centers for Disease Control and Prevention (CDC). Rotavirus surveillance\u2014worldwide, 2001\u20132008. MMWR Morb Mortal Wkly Rep. 2008;57:1255\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"384_CR54","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1016\/j.vaccine.2009.08.098","volume":"27","author":"JE Tate","year":"2009","unstructured":"Tate JE, Chitambar S, Esposito DH, et al. Disease and economic burden of rotavirus diarrhoea in India. Vaccine. 2009;27:S18\u201324.","journal-title":"Vaccine"},{"key":"384_CR55","doi-asserted-by":"publisher","first-page":"S147","DOI":"10.1086\/605031","volume":"200","author":"G Kang","year":"2009","unstructured":"Kang G, Arora R, Chitambar SD, Deshpande J, Gupte MD, Kulkarni M, et al. Multicenter, hospital-based surveillance of rotavirus disease and strains among Indian children aged <5\u00a0years. J Infect Dis. 2009;200:S147\u201353.","journal-title":"J Infect Dis"},{"key":"384_CR56","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1586\/erv.09.136","volume":"8","author":"M O\u2019Ryan","year":"2009","unstructured":"O\u2019Ryan M, Linhares AC. Update on Rotarix: an oral human rotavirus vaccine. Expert Rev Vaccines. 2009;8:1627\u201341.","journal-title":"Expert Rev Vaccines"},{"key":"384_CR57","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1542\/peds.2009-1021","volume":"125","author":"JA Boom","year":"2010","unstructured":"Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010;125:e199\u2013207.","journal-title":"Pediatrics"},{"key":"384_CR58","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S0140-6736(10)60896-3","volume":"376","author":"EA Nelson","year":"2010","unstructured":"Nelson EA, Glass RI. Rotavirus: realising the potential of a promising vaccine. Lancet. 2010;376:568\u201370.","journal-title":"Lancet"},{"key":"384_CR59","first-page":"533","volume":"84","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. Rotavirus vaccines: an update. MMWR Wkly Epidemiol Rec. 2009;84:533\u20138.","journal-title":"MMWR Wkly Epidemiol Rec"},{"key":"384_CR60","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1056\/NEJMe0912141","volume":"362","author":"M Santosham","year":"2010","unstructured":"Santosham M. Rotavirus vaccine\u2014a powerful tool to combat deaths from diarrhea. N Engl J Med. 2010;362:358\u201360.","journal-title":"N Engl J Med"},{"key":"384_CR61","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4161\/hv.5.6.8176","volume":"5","author":"A Narang","year":"2009","unstructured":"Narang A, Bose A, Pandit AN, et al. Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants. Hum Vaccin. 2009;5:414\u20139.","journal-title":"Hum Vaccin"},{"key":"384_CR62","first-page":"220","volume":"84","author":"Anonymous","year":"2009","unstructured":"Anonymous. Meeting of the Immunization Strategic Advisory Group of Experts, April 2009\u2014conclusions and recommendations. Wkly Epidemiol Rec. 2009;84:220\u201336.","journal-title":"Wkly Epidemiol Rec"},{"key":"384_CR63","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","volume":"28","author":"MP Girard","year":"2010","unstructured":"Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: a review. Vaccine. 2010;28:4895\u2013902.","journal-title":"Vaccine"},{"key":"384_CR64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(10)61277-9","volume":"376","author":"Anonymous","year":"2010","unstructured":"Anonymous. Pandemic influenza\u2014(Some) reasons to be cheerful? Lancet. 2010;376:565.","journal-title":"Lancet"},{"key":"384_CR65","doi-asserted-by":"publisher","first-page":"e10540","DOI":"10.1371\/journal.pone.0010540","volume":"5","author":"AC Mishra","year":"2010","unstructured":"Mishra AC, Chadha MS, Choudhary ML, Potdar VA. Pandemic influenza (H1N1) 2009 is associated with severe disease in India. PLoS ONE. 2010;5:e10540.","journal-title":"PLoS ONE"},{"key":"384_CR66","first-page":"67","volume":"132","author":"YK Gurav","year":"2010","unstructured":"Gurav YK, Pawar SD, Chadha MS, et al. Pandemic influenza A (H1N1) 2009 outbreak in a residential school at Panchgani, Maharashtra, India. Indian J Med Res. 2010;132:67\u201371.","journal-title":"Indian J Med Res"},{"key":"384_CR67","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1056\/NEJMoa0908535","volume":"361","author":"FC Zhu","year":"2009","unstructured":"Zhu FC, Wang H, Fang HH, et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med. 2009;361:2414\u201323.","journal-title":"N Engl J Med"},{"key":"384_CR68","doi-asserted-by":"publisher","first-page":"e13755","DOI":"10.1371\/journal.pone.0013755","volume":"5","author":"RM Mallory","year":"2010","unstructured":"Mallory RM, Malkin E, Ambrose CS, et al. Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials. PLoS ONE. 2010;5:e13755.","journal-title":"PLoS ONE"},{"key":"384_CR69","first-page":"iii","volume":"119","author":"VA Arankalle","year":"2004","unstructured":"Arankalle VA. Hepatitis A vaccine strategies and relevance in the present scenario. Indian J Med Res. 2004;119:iii\u2013vi.","journal-title":"Indian J Med Res"},{"key":"384_CR70","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1440-1746.2006.04232.x","volume":"21","author":"Z Hussain","year":"2006","unstructured":"Hussain Z, Das BC, Husain SA, Murthy NS, Kar P. Increasing trend of acute hepatitis A in north India: need for identification of high-risk population for vaccination. J Gastroenterol Hepatol. 2006;21:689\u201393.","journal-title":"J Gastroenterol Hepatol"},{"key":"384_CR71","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.trstmh.2008.11.014","volume":"103","author":"MS Chadha","year":"2009","unstructured":"Chadha MS, Lole KS, Bora MH, Arankalle VA. Outbreaks of hepatitis A among children in western India. Trans R Soc Trop Med Hyg. 2009;103:911\u20136.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"384_CR72","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s12664-010-8003-0","volume":"29","author":"T Samanta","year":"2010","unstructured":"Samanta T, Das AK, Ganguly S. Profile of hepatitis A infection with atypical manifestations in children. Indian J Gastroenterol. 2010;29:31\u20133.","journal-title":"Indian J Gastroenterol"},{"key":"384_CR73","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","volume":"362","author":"P Van Damme","year":"2003","unstructured":"Van Damme P, Banatvala J, Fay O, Iwarson S, McMahon B, Van Herck K, et al. Hepatitis A booster vaccination: is there a need? Lancet. 2003;362:1065\u201371.","journal-title":"Lancet"},{"key":"384_CR74","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1097\/INF.0b013e31806215c8","volume":"26","author":"M Van Der Wielen","year":"2007","unstructured":"Van Der Wielen M, Vertruyen A, Froesner G, et al. Immunogenicity and safety of a pediatric dose of a virosome-adjuvanted hepatitis A vaccine: a controlled trial in children aged 1\u201316\u00a0years. Pediatr Infect Dis J. 2007;26:705\u201310.","journal-title":"Pediatr Infect Dis J"},{"key":"384_CR75","first-page":"983","volume":"43","author":"S Bhave","year":"2006","unstructured":"Bhave S, Bavdekar A, Madan Z, et al. Evaluation of immunogenicity and tolerability of a live attenuated hepatitis a vaccine in Indian children. Indian Pediatr. 2006;43:983\u20137.","journal-title":"Indian Pediatr"},{"key":"384_CR76","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.vaccine.2006.08.004","volume":"25","author":"XY Wang","year":"2007","unstructured":"Wang XY, Xu ZY, Ma JC, et al. Long-term immunogenicity after single and booster dose of a live attenuated hepatitis A vaccine: results from 8-year follow-up. Vaccine. 2007;25:446\u20139.","journal-title":"Vaccine"},{"key":"384_CR77","first-page":"29","volume":"46","author":"MM Faridi","year":"2009","unstructured":"Faridi MM, Shah N, Ghosh TK, et al. Immunogenicity and safety of live attenuated Hepatitis A vaccine: a multicentric study. Indian Pediatr. 2009;46:29\u201334.","journal-title":"Indian Pediatr"},{"key":"384_CR78","doi-asserted-by":"publisher","first-page":"185","DOI":"10.2471\/BLT.09.073460","volume":"88","author":"S Kanungo","year":"2010","unstructured":"Kanungo S, Sah BK, Lopez AL, et al. Cholera in India: an analysis of reports, 1997\u20132006. Bull World Health Organ. 2010;88:185\u201391.","journal-title":"Bull World Health Organ"},{"key":"384_CR79","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2217\/fmb.09.9","volume":"4","author":"J Clemens","year":"2009","unstructured":"Clemens J, Holmgren J. Urgent need of cholera vaccines in public health-control programs. Future Microbiol. 2009;4:381\u20135.","journal-title":"Future Microbiol"},{"key":"384_CR80","first-page":"1","volume":"131","author":"D Sur","year":"2010","unstructured":"Sur D, Nair GB, Lopez AL, Clemens JD, Katoch VM, Ganguly NK. Oral cholera vaccines\u2014a call for action. Indian J Med Res. 2010;131:1\u20133.","journal-title":"Indian J Med Res"},{"key":"384_CR81","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/S0140-6736(09)61297-6","volume":"374","author":"D Sur","year":"2009","unstructured":"Sur D, Lopez AL, Kanungo S, et al. Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1694\u2013702.","journal-title":"Lancet"},{"key":"384_CR82","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/S0140-6736(09)61418-5","volume":"374","author":"S Sridhar","year":"2009","unstructured":"Sridhar S. An affordable cholera vaccine: an important step forward. Lancet. 2009;374:1658\u201360.","journal-title":"Lancet"},{"key":"384_CR83","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","volume":"24","author":"T Tan","year":"2005","unstructured":"Tan T, Trindade E, Skowronski D. Epidemiology of pertussis. Pediatr Infect Dis J. 2005;24:S10\u20138.","journal-title":"Pediatr Infect Dis J"},{"key":"384_CR84","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1016\/S0140-6736(06)68848-X","volume":"367","author":"NS Crowcroft","year":"2006","unstructured":"Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367:1926\u201336.","journal-title":"Lancet"},{"key":"384_CR85","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1542\/peds.2005-3038","volume":"117","author":"America Academy of Pediatrics Commitee on Infectious Diseases","year":"2006","unstructured":"America Academy of Pediatrics Commitee on Infectious Diseases. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine. Pediatrics. 2006;117:965\u201378.","journal-title":"Pediatrics"},{"key":"384_CR86","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1086\/653938","volume":"51","author":"SC Wei","year":"2010","unstructured":"Wei SC, Tatti K, Cushing K, et al. Effectiveness of adolescent and adult tetanus, reduced-dose diphtheria, and acellular pertussis vaccine against pertussis. Clin Infect Dis. 2010;51:315\u201321.","journal-title":"Clin Infect Dis"},{"key":"384_CR87","first-page":"421","volume":"44","author":"A Bose","year":"2007","unstructured":"Bose A, Dubey AP, Gandhi D, et al. Safety and reactogenicity of a low dose diphtheria tetanus acellular pertussis vaccine (Boostrix) in pre-school Indian children. Indian Pediatr. 2007;44:421\u20134.","journal-title":"Indian Pediatr"},{"key":"384_CR88","first-page":"327","volume":"130","author":"M Bharadwaj","year":"2009","unstructured":"Bharadwaj M, Hussain S, Nasare V, Das BC. HPV & HPV vaccination: issues in developing countries. Indian J Med Res. 2009;130:327\u201333.","journal-title":"Indian J Med Res"},{"key":"384_CR89","first-page":"219","volume":"130","author":"A Nandakumar","year":"2009","unstructured":"Nandakumar A, Ramnath T, Chaturvedi M. The magnitude of cancer cervix in India. Indian J Med Res. 2009;130:219\u201321.","journal-title":"Indian J Med Res"},{"key":"384_CR90","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2334-5-116","volume":"5","author":"AP Sowjanya","year":"2005","unstructured":"Sowjanya AP, Jain M, Poli UR, et al. Prevalence and distribution of high-risk human papilloma virus (HPV) types in invasive squamous cell carcinoma of the cervix and in normal women in Andhra Pradesh, India. BMC Infect Dis. 2005;5:116.","journal-title":"BMC Infect Dis"},{"key":"384_CR91","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/IGC.0b013e3181e02fe0","volume":"20","author":"RM Pillai","year":"2010","unstructured":"Pillai RM, Babu JM, Jissa VT, et al. Region-wise distribution of high-risk human papillomavirus types in squamous cell carcinomas of the cervix in India. Int J Gynecol Cancer. 2010;20:1046\u201351.","journal-title":"Int J Gynecol Cancer"},{"key":"384_CR92","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.2165\/10898580-000000000-00000","volume":"70","author":"SM Garland","year":"2010","unstructured":"Garland SM, Smith JS. Human papillomavirus vaccines: current status and future prospects. Drugs. 2010;70:1079\u201398.","journal-title":"Drugs"},{"key":"384_CR93","doi-asserted-by":"publisher","first-page":"7236","DOI":"10.1016\/j.vaccine.2009.05.019","volume":"27","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. WHO position on HPV vaccines. Vaccine. 2009;27:7236\u20137.","journal-title":"Vaccine"}],"container-title":["The Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-011-0384-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-011-0384-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-011-0384-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-011-0384-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:51:05Z","timestamp":1744149065000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-011-0384-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,5]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s12098-011-0384-2","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"type":"print","value":"0019-5456"},{"type":"electronic","value":"0973-7693"}],"subject":[],"published":{"date-parts":[[2011,3,5]]},"assertion":[{"value":"4 January 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2011","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2011","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}